These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 6478412)

  • 1. Aminoglutethimide-induced bone marrow injury. Report of a case and review of the literature.
    Young JA; Newcomer LN; Keller AM
    Cancer; 1984 Oct; 54(8):1731-3. PubMed ID: 6478412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Transient bone marrow inhibition caused by aminoglutethimide].
    Tel W; van Lijf JH; ten Napel CH
    Ned Tijdschr Geneeskd; 1989 Jan; 133(3):126-8. PubMed ID: 2922066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancytopenia induced by aminoglutethimide in the treatment of breast cancer.
    Lawrence B; Santen RJ; Lipton A; Harvey HA; Hamilton R; Mercurio T
    Cancer Treat Rep; 1978 Oct; 62(10):1581-3. PubMed ID: 213192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglutethimide-induced leukopenia: a case report and review of the literature.
    Gez E; Sulkes A
    Oncology; 1984; 41(6):399-402. PubMed ID: 6504495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible thrombocytopenia following aminoglutethimide.
    Kissin MW; Kark AE
    Cancer Treat Rep; 1983 Sep; 67(9):849. PubMed ID: 6883365
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglutethimide-induced hematologic toxicity: worldwide experience.
    Messeih AA; Lipton A; Santen RJ; Harvey HA; Boucher AE; Murray R; Ragaz J; Buzdar AU; Nagel GA; Henderson IC
    Cancer Treat Rep; 1985 Sep; 69(9):1003-4. PubMed ID: 4028032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Agranulocytosis associated with aminoglutethimide: pharmacological and marrow studies.
    Harris AL; Hughes G; Barrett AJ; Abusrewil S; Dowsett M; Smith IE
    Br J Cancer; 1986 Jul; 54(1):119-22. PubMed ID: 3730249
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglutethimide-induced myelosuppression.
    van der Heijden JT; Splinter TA
    Breast Cancer Res Treat; 1986; 7(3):211-2. PubMed ID: 3779118
    [No Abstract]   [Full Text] [Related]  

  • 9. Aminoglutethimide-induced hyperkalaemia.
    Davies JP; Bentley P; Ghose RR
    Br J Clin Pract; 1989 Jul; 43(7):263-4. PubMed ID: 2597612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Panmyelopathy induced by aminoglutethimide. Report of a clinical case].
    Wander HE
    Onkologie; 1984 Dec; 7(6):367-9. PubMed ID: 6396564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
    Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aminoglutethimide therapy in advanced breast cancer].
    Kühböck J; Ludwig H; Pötzi P; Zielinski C
    Wien Med Wochenschr; 1985 Dec; 135(23-24):608-11. PubMed ID: 4096007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglutethimide (with hydrocortisone) induced agranulocytosis in primary breast cancer.
    Vincent MD; Clink HM; Coombes RC; Smith IE; Kandler R; Powles TJ
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):105-6. PubMed ID: 2990631
    [No Abstract]   [Full Text] [Related]  

  • 14. Aminoglutethimide as second line endocrine therapy in advanced breast cancer.
    Brufman G; Biran S
    Anticancer Res; 1986; 6(5):1065-8. PubMed ID: 3800315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of metastatic breast cancer with aminoglutethimide.
    Asbury RF; Bakemeier RF; Fölsch E; McCune CS; Savlov E; Bennett JM
    Cancer; 1981 Apr; 47(8):1954-8. PubMed ID: 7226090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agranulocytosis induced by aminoglutethimide.
    Mathijs R; Coolen D; Hermans-Debaive C
    Acta Clin Belg; 1988; 43(2):146-8. PubMed ID: 2840788
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoglutethimide induced agranulocytosis in breast cancer.
    Caldwell G; Bradbury A; Toft AD
    Br Med J (Clin Res Ed); 1985 Oct; 291(6500):970-1. PubMed ID: 3929986
    [No Abstract]   [Full Text] [Related]  

  • 18. Leukopenia associated with aminoglutethimide therapy: a case report.
    Austerlitz J
    Cancer Treat Rep; 1982 Oct; 66(10):1879. PubMed ID: 7127328
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of metastatic breast cancer with aminoglutethimide after progression on chemotherapy and/or hormonal therapy with tamoxifen.
    Brufman G; Biran S
    Eur J Surg Oncol; 1985 Mar; 11(1):27-31. PubMed ID: 2985452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aminoglutethimide treatment in advanced breast cancer: an efficient therapy as a late endocrine alternative in a sequential therapeutic approach.
    Kvinnsland S; Dahl O
    Breast Cancer Res Treat; 1983; 3(1):73-6. PubMed ID: 6871483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.